Intellectus Partners’s Thermo Fisher Scientific TMO Stock Holding History

Intellectus Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Buy	519 +56	+12%	+$26.9K	0.05%	275
2026 Q1	$228K	Buy	463 +6	+1%	+$3.26K	0.05%	266
2025 Q4	$265K	Hold	457	–	–	0.05%	247
2025 Q3	$222K	Sell	457 -1,487	-76%	-$692K	0.04%	260
2025 Q2	$789K	Hold	1,944	–	–	0.17%	152
2025 Q1	$968K	Sell	1,944 -88	-4%	-$47.7K	0.24%	125
2024 Q4	$1.06M	Hold	2,032	–	–	0.23%	111
2024 Q3	$1.26M	Hold	2,032	–	–	0.32%	92
2024 Q2	$1.12M	Sell	2,032 -185	-8%	-$106K	0.31%	88
2024 Q1	$1.29M	Buy	2,217 +1,285	+138%	+$721K	0.34%	84
2023 Q4	$495K	Sell	932 -13	-1%	-$6.29K	0.14%	176
2023 Q3	$479K	Sell	945 -8	-0.8%	-$4.26K	0.15%	177
2023 Q2	$498K	Hold	953	–	–	0.15%	180
2023 Q1	$550K	Hold	953	–	–	0.17%	163
2022 Q4	$525K	Buy	+953	New	+$505K	0.18%	159

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Intellectus Partners's TMO Position: Q2 2026 in Review

Intellectus Partners increased its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, buying an estimated $26.9K and bringing the position to 519 shares worth $261K. The position accounts for 0.05% of the portfolio, ranked #275.

Intellectus Partners first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.29M in Q1 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Intellectus Partners held 519 shares of Thermo Fisher Scientific worth $261K as of Q2 2026.
Intellectus Partners bought 56 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.9K.
Thermo Fisher Scientific made up 0.05% of Intellectus Partners's portfolio in Q2 2026, its #275 holding.
Intellectus Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Intellectus Partners's Thermo Fisher Scientific position peaked at $1.29M in Q1 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.